Genomic Cancer Panel and Profiling Market, By Testing Type, By Technology, By Cancer Type, By End-Use, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Genomic Cancer Panel and Profiling Market size was valued at USD 11,680.7 Million in 2025, expanding to a CAGR of 8.9% from 2026 to 2033.

Genomic cancer panel and profiling is a diagnostic technique to determine the genetic makeup of a patient's tumor. It looks at DNA, RNA and other genetic material to find changes that could be causing the cancer to grow and progress. The test uses advanced sequencing technologies to simultaneously assess multiple genes and is able to detect mutations, gene fusions, copy number variations, and other types of molecular changes. The knowledge gained helps healthcare providers to better understand the unique characteristics of a cancer and make better treatment decisions.

Genomic Cancer Panel and Profiling Market- Market Dynamics

Increasing enterprise demand for cloud-native applications and growing automation, Ai integration are expected to propel market demand

One of the primary factors driving growth in the genomic cancer panel and profiling market is the increasing adoption of precision oncology. Cancer treatment is shifting away from a one-size-fits-all approach toward therapies tailored to the genetic makeup of an individual patient's tumor. Genomic profiling can assist oncologists in detecting actionable mutations, gene fusions and other molecular biomarkers that impact the development and treatment of a cancer. This allows for the identification of targeted therapies and immunotherapies that can increase the effectiveness of treatment and improve patient outcomes and reduce exposure to less effective treatment options. The rising global burden of cancer is also contributing significantly to market expansion. According to the World Health Organization (WHO), 35 million new cancer cases are expected to be diagnosed worldwide by 2050, and the number is expected to continue further.

As cancer incidence grows, healthcare systems are placing greater emphasis on advanced diagnostic tools that support personalized treatment planning. Genomic cancer profiling helps physicians identify the most appropriate therapeutic strategies at an earlier stage, minimizes trial-and-error treatment decisions, and improves patient selection for clinical trials. Furthermore, the growing availability of targeted oncology drugs and companion diagnostics has increased the clinical relevance of genomic testing, making comprehensive molecular profiling an increasingly important component of modern cancer care.

The genomic cancer panel and profiling market is growing with the help of constant improvements in genomic sequencing technologies, especially next-generation sequencing (NGS). The ability to identify genetic changes that are related to cancer has improved greatly over the years with improvements in sequencing speed, accuracy, and data analysis. Automation has also been increased, making the testing processes more streamlined, and the results can be delivered more efficiently. As a result, more and more healthcare providers are integrating genomic profiling into the routine diagnosis and treatment planning for cancer, which is fueling the market growth.

Genomic Cancer Panel and Profiling Market- Segmentation Analysis:

The Global Genomic Cancer Panel and Profiling Market is segmented on the basis of Testing Type, Technology, Cancer Type, End-Use, Application, and Region.

The market is divided into seven categories based on Testing Type: Comprehensive Genomic Profiling (CGP), Targeted Gene Panels, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), liquid biopsy-based genomic profiling, solid biopsy-based genomic profiling, and others. Comprehensive Genomic Profiling (CGP) holds the substantial share of the genomic cancer panel and profiling market because it provides a detailed molecular understanding of tumors through a single test. Unlike targeted gene panels, which focus on a limited number of predefined genes, CGP analyzes hundreds of cancer-related genes simultaneously, offering a more comprehensive view of a tumor's genetic makeup. This broader approach helps identify a wide range of genomic alterations, including gene mutations, copy number changes, gene rearrangements, etc.

Genomic Cancer Panel and Profiling Market- Geographical Insights

North America's market growth is being strongly supported by the increasing integration of precision medicine into routine cancer care. Leading cancer research institutions, academic medical centers, and specialized oncology clinics are making greater use of genomic profiling to tailor treatment plans to individual patients. Through collaboration between healthcare providers, research organizations and industry stakeholders to develop new genomic testing, the region's precision oncology landscape has been strengthened, driving wider adoption of comprehensive genomic profiling into clinical practice. In Europe, the market is growing because of the increasing use of liquid biopsy technologies and advanced genomic analysis solutions.

Healthcare providers are increasingly turning to blood-based genomic testing as a less invasive alternative to conventional tissue biopsies, particularly for cancer detection, disease monitoring, and evaluating treatment effectiveness. At the same time, artificial intelligence, machine learning, and advanced bioinformatics tools are improving the analysis and interpretation of complex genomic data. These technologies enable clinicians to generate faster and more accurate insights, supporting better-informed treatment decisions and contributing to the growing adoption of genomic profiling across the region.

United States Genomic Cancer Panel and Profiling Market- Key Insights

The United States is the prominent market for genomic cancer panels and profiling, supported by its strong emphasis on precision medicine, well-established healthcare infrastructure, and widespread use of molecular diagnostics in cancer care. As oncology increasingly moves toward biomarker-driven treatment approaches, healthcare providers are making genomic testing a routine part of clinical decision-making. The growing cancer burden is also contributing to demand for advanced diagnostic solutions. According to the American Cancer Society, more than 2 million new cancer cases are expected to be diagnosed annually in the United States, underscoring the need for technologies that can help deliver more personalized and effective treatment strategies. In addition, the rising number of FDA-approved targeted cancer therapies is further increasing the importance of genomic profiling, as these tests help identify patients who are most likely to benefit from specific treatments.

Genomic Cancer Panel and Profiling Market- Competitive Landscape:

The genomic cancer panel and profiling market is highly competitive, with diagnostic companies, sequencing technology providers, biotechnology firms, and specialized molecular testing laboratories all striving to strengthen their presence in the growing precision oncology space. As demand for personalized cancer care continues to rise, companies are investing heavily in expanding their testing portfolios, improving sequencing performance, and advancing bioinformatics tools that can deliver deeper and more clinically meaningful insights into tumor genetics.

A major area of focus is the development of more comprehensive genomic profiling solutions that help clinicians identify actionable mutations and select the most appropriate treatment options for patients. To support this goal, many diagnostic companies are collaborating with pharmaceutical and biotechnology firms to develop companion diagnostics that can determine which patients are most likely to benefit from specific targeted therapies or immunotherapies.

Recent Developments:

In April 2025, Guardant Health announced a long-term partnership with Pfizer aimed at advancing the development and commercialization of precision oncology treatments through its Infinity liquid biopsy platform. The collaboration leverages blood-based genomic testing and circulating tumor DNA (ctDNA) technologies to support biomarker identification.

In May 2025, Illumina strengthened its presence in precision oncology by broadening the availability of its TruSight Oncology Comprehensive assay and enhancing reimbursement support for comprehensive genomic profiling services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET KEY PLAYERS

Illumina, Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
QIAGEN N.V.
Agilent Technologies, Inc.
Guardant Health, Inc.
Exact Sciences Corporation
Foundation Medicine, Inc.
Caris Life Sciences
Tempus AI, Inc.
NeoGenomics Laboratories, Inc.
Myriad Genetics, Inc.
Natera, Inc.
BGI Genomics Co., Ltd.
Personalis, Inc.
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2020-2033

Comprehensive Genomic Profiling (CGP)
Targeted Gene Panels
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033

Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence in Situ Hybridization (FISH)
Microarray Analysis
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Hematological Malignancies
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

Hospitals
Clinical Diagnostic Laboratories
CROs
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

Clinical Diagnostics
Biomarker Discovery
Companion Diagnostics
Drug Discovery & Development
Research Applications
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6885

1. Genomic Cancer Panel and Profiling Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Genomic Cancer Panel and Profiling Market Snippet by Testing Type
- 2.1.2. Genomic Cancer Panel and Profiling Market Snippet by Technology
- 2.1.3. Genomic Cancer Panel and Profiling Market Snippet by Cancer Type
- 2.1.4. Genomic Cancer Panel and Profiling Market Snippet by End-Use
- 2.1.5. Genomic Cancer Panel and Profiling Market Snippet by Application
- 2.1.6. Genomic Cancer Panel and Profiling Market Snippet by Country
- 2.1.7. Genomic Cancer Panel and Profiling Market Snippet by Region
2.2. Competitive Insights

3. Genomic Cancer Panel and Profiling Key Market Trends

3.1. Genomic Cancer Panel and Profiling Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Genomic Cancer Panel and Profiling Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Genomic Cancer Panel and Profiling Market Opportunities
3.4. Genomic Cancer Panel and Profiling Market Future Trends

4. Genomic Cancer Panel and Profiling Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Genomic Cancer Panel and Profiling Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Genomic Cancer Panel and Profiling Market Landscape

6.1. Genomic Cancer Panel and Profiling Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Genomic Cancer Panel and Profiling Market - By Testing Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Testing Type, 2025 & 2033 (%)
- 7.1.2. Comprehensive Genomic Profiling (CGP)
- 7.1.3. Targeted Gene Panels
- 7.1.4. Whole Genome Sequencing (WGS)
- 7.1.5. Whole Exome Sequencing (WES)
- 7.1.6. Others

8. Genomic Cancer Panel and Profiling Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
- 8.1.2. Next-Generation Sequencing (NGS)
- 8.1.3. Polymerase Chain Reaction (PCR)
- 8.1.4. Fluorescence in Situ Hybridization (FISH)
- 8.1.5. Microarray Analysis
- 8.1.6. Others

9. Genomic Cancer Panel and Profiling Market - By Cancer Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Cancer Type, 2025 & 2033 (%)
- 9.1.2. Breast Cancer
- 9.1.3. Lung Cancer
- 9.1.4. Colorectal Cancer
- 9.1.5. Prostate Cancer
- 9.1.6. Hematological Malignancies
- 9.1.7. Others

10. Genomic Cancer Panel and Profiling Market - By End-Use

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
- 10.1.2. Hospitals
- 10.1.3. Clinical Diagnostic Laboratories
- 10.1.4. CROs
- 10.1.5. Others

11. Genomic Cancer Panel and Profiling Market - By Application

11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 11.1.2. Clinical Diagnostics
- 11.1.3. Biomarker Discovery
- 11.1.4. Companion Diagnostics
- 11.1.5. Drug Discovery & Development
- 11.1.6. Research Applications
- 11.1.7. Others

12. Genomic Cancer Panel and Profiling Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Genomic Cancer Panel and Profiling Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Genomic Cancer Panel and Profiling Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Genomic Cancer Panel and Profiling Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Genomic Cancer Panel and Profiling Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Genomic Cancer Panel and Profiling Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Genomic Cancer Panel and Profiling Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Illumina, Inc.
- 13.2.2. Thermo Fisher Scientific Inc.
- 13.2.3. F. Hoffmann-La Roche Ltd
- 13.2.4. QIAGEN N.V.
- 13.2.5. Agilent Technologies, Inc.
- 13.2.6. Guardant Health, Inc.
- 13.2.7. Exact Sciences Corporation
- 13.2.8. Foundation Medicine, Inc.
- 13.2.9. Caris Life Sciences
- 13.2.10. Tempus AI, Inc.
- 13.2.11. NeoGenomics Laboratories, Inc.
- 13.2.12. Myriad Genetics, Inc.
- 13.2.13. Natera, Inc.
- 13.2.14. BGI Genomics Co., Ltd.
- 13.2.15. Personalis, Inc.
- 13.2.16. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us